TJP1 and metabolic dysfunction-associated steatotic liver disease: Furthermore, CBM 588 significantly reduces serum endotoxin levels and hepatic inflammatory indexes and dramatically enhances TJ protein expression (ZO-1 and occludin) in rats with nonalcoholic fatty liver disease [41].